Memphasys Limited MEM.AX Stock
Memphasys Limited Price Chart
Memphasys Limited MEM.AX Financial and Trading Overview
| Memphasys Limited stock price | 0.0080 AUD |
| Previous Close | 0.02 AUD |
| Open | 0.02 AUD |
| Bid | 0.02 AUD x 0 |
| Ask | 0.02 AUD x 0 |
| Day's Range | 0.02 - 0.02 AUD |
| 52 Week Range | 0.01 - 0.06 AUD |
| Volume | 952.24K AUD |
| Avg. Volume | 491.07K AUD |
| Market Cap | 16.31M AUD |
| Beta (5Y Monthly) | 0.101915 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MEM.AX Valuation Measures
| Enterprise Value | 18.72M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 227.04211 |
| Price/Book (mrq) | 1.7000002 |
| Enterprise Value/Revenue | 260.583 |
| Enterprise Value/EBITDA | -6.126 |
Trading Information
Memphasys Limited Stock Price History
| Beta (5Y Monthly) | 0.101915 |
| 52-Week Change | -54.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 AUD |
| 52 Week Low | 0.01 AUD |
| 50-Day Moving Average | 0.02 AUD |
| 200-Day Moving Average | 0.02 AUD |
MEM.AX Share Statistics
| Avg. Volume (3 month) | 491.07K AUD |
| Avg. Daily Volume (10-Days) | 876.02K AUD |
| Shares Outstanding | 959.52M |
| Float | 379.63M |
| Short Ratio | N/A |
| % Held by Insiders | 62.06% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4354.49% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -12.80% |
| Return on Equity (ttm) | -25.42% |
Income Statement
| Revenue (ttm) | 71.85K AUD |
| Revenue Per Share (ttm) | 0 AUD |
| Quarterly Revenue Growth (yoy) | -68.50% |
| Gross Profit (ttm) | 62.24K AUD |
| EBITDA | -3056150 AUD |
| Net Income Avi to Common (ttm) | -2327579 AUD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.1M AUD |
| Total Cash Per Share (mrq) | 0.002 AUD |
| Total Debt (mrq) | 5.46M AUD |
| Total Debt/Equity (mrq) | 57.3 AUD |
| Current Ratio (mrq) | 0.711 |
| Book Value Per Share (mrq) | 0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 317.66K AUD |
| Levered Free Cash Flow (ttm) | -4601668 AUD |
Profile of Memphasys Limited
| Country | Australia |
| State | NSW |
| City | Homebush |
| Address | 30 Richmond Road |
| ZIP | 2140 |
| Phone | 61 2 8415 7300 |
| Website | https://www.memphasys.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.
Q&A For Memphasys Limited Stock
What is a current MEM.AX stock price?
Memphasys Limited MEM.AX stock price today per share is 0.0080 AUD.
How to purchase Memphasys Limited stock?
You can buy MEM.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Memphasys Limited?
The stock symbol or ticker of Memphasys Limited is MEM.AX.
Which industry does the Memphasys Limited company belong to?
The Memphasys Limited industry is Biotechnology.
How many shares does Memphasys Limited have in circulation?
The max supply of Memphasys Limited shares is 1.37B.
What is Memphasys Limited Price to Earnings Ratio (PE Ratio)?
Memphasys Limited PE Ratio is now.
What was Memphasys Limited earnings per share over the trailing 12 months (TTM)?
Memphasys Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Memphasys Limited company belong to?
The Memphasys Limited sector is Healthcare.